• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 Alpha 变体与苏格兰 COVID-19 临床严重程度增加相关:基于基因组学的回顾性队列分析。

The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.

机构信息

MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.

Joint Universities Pandemic and Epidemiological Research (JUNIPER) Consortium, United Kingdom.

出版信息

PLoS One. 2023 Apr 13;18(4):e0284187. doi: 10.1371/journal.pone.0284187. eCollection 2023.

DOI:10.1371/journal.pone.0284187
PMID:37053201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10101505/
Abstract

OBJECTIVES

The SARS-CoV-2 Alpha variant was associated with increased transmission relative to other variants present at the time of its emergence and several studies have shown an association between Alpha variant infection and increased hospitalisation and 28-day mortality. However, none have addressed the impact on maximum severity of illness in the general population classified by the level of respiratory support required, or death. We aimed to do this.

METHODS

In this retrospective multi-centre clinical cohort sub-study of the COG-UK consortium, 1475 samples from Scottish hospitalised and community cases collected between 1st November 2020 and 30th January 2021 were sequenced. We matched sequence data to clinical outcomes as the Alpha variant became dominant in Scotland and modelled the association between Alpha variant infection and severe disease using a 4-point scale of maximum severity by 28 days: 1. no respiratory support, 2. supplemental oxygen, 3. ventilation and 4. death.

RESULTS

Our cumulative generalised linear mixed model analyses found evidence (cumulative odds ratio: 1.40, 95% CI: 1.02, 1.93) of a positive association between increased clinical severity and lineage (Alpha variant versus pre-Alpha variants).

CONCLUSIONS

The Alpha variant was associated with more severe clinical disease in the Scottish population than co-circulating lineages.

摘要

目的

SARS-CoV-2 的 Alpha 变体与其他变体相比,在其出现时具有更高的传播性,并且有几项研究表明 Alpha 变体感染与住院和 28 天死亡率增加之间存在关联。然而,没有研究涉及到根据所需呼吸支持水平对一般人群中疾病严重程度的最大程度的影响,也没有研究涉及到死亡。我们旨在解决这个问题。

方法

在 COG-UK 联盟的这项回顾性多中心临床队列子研究中,对 2020 年 11 月 1 日至 2021 年 1 月 30 日期间苏格兰住院和社区病例采集的 1475 个样本进行了测序。我们将序列数据与临床结果相匹配,因为 Alpha 变体在苏格兰占据主导地位,并使用 28 天内的严重程度 4 分制(1.无呼吸支持,2.补充氧气,3.通气,4.死亡)来模拟 Alpha 变体感染与严重疾病之间的关联。

结果

我们的累积广义线性混合模型分析发现了证据(累积优势比:1.40,95%CI:1.02,1.93),表明临床严重程度与谱系(Alpha 变体与前 Alpha 变体)之间存在正相关。

结论

与同时流行的谱系相比,Alpha 变体在苏格兰人群中与更严重的临床疾病相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/b605d5f9d30a/pone.0284187.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/3108aefcb717/pone.0284187.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/991ea573cd5a/pone.0284187.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/b605d5f9d30a/pone.0284187.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/3108aefcb717/pone.0284187.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/991ea573cd5a/pone.0284187.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4245/10101505/b605d5f9d30a/pone.0284187.g003.jpg

相似文献

1
The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis.SARS-CoV-2 Alpha 变体与苏格兰 COVID-19 临床严重程度增加相关:基于基因组学的回顾性队列分析。
PLoS One. 2023 Apr 13;18(4):e0284187. doi: 10.1371/journal.pone.0284187. eCollection 2023.
2
Emerging Variants of SARS-CoV-2 and Novel Therapeutics Against Coronavirus (COVID-19)严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的新变种及针对冠状病毒(COVID-19)的新型疗法
3
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study.苏格兰患者中与德尔塔变异株(B.1.617.2)及第二剂接种后时间相关的针对重症 COVID-19 的疫苗效力(REACT-SCOT):一项病例对照研究
Lancet Respir Med. 2022 Jun;10(6):566-572. doi: 10.1016/S2213-2600(22)00045-5. Epub 2022 Feb 25.
4
Pregnancy outcomes after SARS-CoV-2 infection in periods dominated by delta and omicron variants in Scotland: a population-based cohort study.苏格兰地区德尔塔和奥密克戎变异株为主流行期间感染 SARS-CoV-2 后的妊娠结局:一项基于人群的队列研究。
Lancet Respir Med. 2022 Dec;10(12):1129-1136. doi: 10.1016/S2213-2600(22)00360-5. Epub 2022 Oct 7.
5
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.COVID-19 疫苗对 Delta AY.4.2 引起的有症状 SARS-CoV-2 感染和重症 COVID-19 的有效性:苏格兰 540 万人的队列和阴性测试研究。
J Glob Health. 2022 Jul 9;12:05025. doi: 10.7189/jogh.12.05025.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020.评估与 SARS-CoV-2 Alpha 变异株感染相关的死亡率和住院人数:2020 年 10 月至 12 月,英格兰匹配队列和时间事件分析。
Euro Surveill. 2022 May;27(20). doi: 10.2807/1560-7917.ES.2022.27.20.2100377.
8
Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study.使用国家实时患者层面数据平台对苏格兰新冠肺炎住院和死亡情况的时间趋势及预测:一项统计建模研究
Lancet Digit Health. 2021 Aug;3(8):e517-e525. doi: 10.1016/S2589-7500(21)00105-9. Epub 2021 Jul 5.
9
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.SARS-CoV-2 的 Alpha、Delta 和奥密克戎变异株的替代动力学和发病机制。
Epidemiol Infect. 2022 Dec 20;151:e32. doi: 10.1017/S0950268822001935.
10
Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.SARS-CoV-2 感染后神经和精神风险轨迹:包括 1284437 名患者的 2 年回顾性队列研究分析。
Lancet Psychiatry. 2022 Oct;9(10):815-827. doi: 10.1016/S2215-0366(22)00260-7. Epub 2022 Aug 17.

引用本文的文献

1
SARS-CoV-2 Variants: Genetic Insights, Epidemiological Tracking, and Implications for Vaccine Strategies.严重急性呼吸综合征冠状病毒2变种:遗传学见解、流行病学追踪及其对疫苗策略的影响
Int J Mol Sci. 2025 Jan 31;26(3):1263. doi: 10.3390/ijms26031263.
2
Impact of tiered restrictions in December 2020 on COVID-19 hospitalisations in England: a synthetic control study.2020年12月分层限制措施对英格兰新冠肺炎住院情况的影响:一项合成对照研究
BMJ Open. 2025 Jan 4;15(1):e086802. doi: 10.1136/bmjopen-2024-086802.
3
A phylogenetics and variant calling pipeline to support SARS-CoV-2 genomic epidemiology in the UK.

本文引用的文献

1
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.SARS-CoV-2 奥密克戎是一种具有改变的细胞进入途径的免疫逃逸变体。
Nat Microbiol. 2022 Aug;7(8):1161-1179. doi: 10.1038/s41564-022-01143-7. Epub 2022 Jul 7.
2
Assessment of mortality and hospital admissions associated with confirmed infection with SARS-CoV-2 Alpha variant: a matched cohort and time-to-event analysis, England, October to December 2020.评估与 SARS-CoV-2 Alpha 变异株感染相关的死亡率和住院人数:2020 年 10 月至 12 月,英格兰匹配队列和时间事件分析。
Euro Surveill. 2022 May;27(20). doi: 10.2807/1560-7917.ES.2022.27.20.2100377.
3
一种支持英国新冠病毒基因组流行病学研究的系统发育学与变异体检测流程。
Virus Evol. 2024 Oct 17;10(1):veae083. doi: 10.1093/ve/veae083. eCollection 2024.
4
Clinical profiles and mortality predictors of hospitalized patients with COVID-19 in Ethiopia.在埃塞俄比亚住院的 COVID-19 患者的临床特征和死亡预测因素。
BMC Infect Dis. 2024 Sep 2;24(1):908. doi: 10.1186/s12879-024-09836-6.
5
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein.关注的 SARS-CoV-2 RBD 变异株中观察到的突变及其对与 ACE2 蛋白相互作用的影响的比较研究。
J Phys Chem B. 2023 Oct 12;127(40):8586-8602. doi: 10.1021/acs.jpcb.3c01467. Epub 2023 Sep 29.
6
Seven Epidemic Waves of COVID-19 in a Hospital in Madrid: Analysis of Severity and Associated Factors.马德里一家医院的 COVID-19 七波疫情:严重程度分析及相关因素。
Viruses. 2023 Aug 30;15(9):1839. doi: 10.3390/v15091839.
7
SARS-CoV-2 Variants of Concern and Clinical Severity in the Mexican Pediatric Population.墨西哥儿科人群中值得关注的新型冠状病毒2(SARS-CoV-2)变异株与临床严重程度
Infect Dis Rep. 2023 Sep 11;15(5):535-548. doi: 10.3390/idr15050053.
8
Whole-genome sequence analysis reveals the circulation of multiple SARS-CoV-2 variants of concern in Nairobi and neighboring counties, Kenya between March and July 2021.全基因组序列分析揭示了 2021 年 3 月至 7 月期间肯尼亚内罗毕和周边县的多种引起关注的 SARS-CoV-2 变异株的传播。
Virol J. 2022 Nov 8;19(1):178. doi: 10.1186/s12985-022-01895-y.
9
Benchmark datasets for SARS-CoV-2 surveillance bioinformatics.用于 SARS-CoV-2 监测生物信息学的基准数据集。
PeerJ. 2022 Sep 5;10:e13821. doi: 10.7717/peerj.13821. eCollection 2022.
Descriptive comparison of admission characteristics between pandemic waves and multivariable analysis of the association of the Alpha variant (B.1.1.7 lineage) of SARS-CoV-2 with disease severity in inner London.
大流行波期间入院特征的描述性比较和 SARS-CoV-2 的 Alpha 变体(B.1.1.7 谱系)与伦敦市内疾病严重程度的多变量分析。
BMJ Open. 2022 Feb 8;12(2):e055474. doi: 10.1136/bmjopen-2021-055474.
4
Evolution of enhanced innate immune evasion by SARS-CoV-2.SARS-CoV-2 增强的先天免疫逃避进化。
Nature. 2022 Feb;602(7897):487-495. doi: 10.1038/s41586-021-04352-y. Epub 2021 Dec 23.
5
SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study.SARS-CoV-2 谱系 B.1.1.7 与住院女性患者的疾病严重程度增加相关,但与男性患者无关:多中心队列研究。
BMJ Open Respir Res. 2021 Sep;8(1). doi: 10.1136/bmjresp-2021-001029.
6
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England.英格兰严重急性呼吸系统综合征冠状病毒 2 型(SARS-CoV-2)阿尔法变异株(B.1.1.7)的严重程度。
Clin Infect Dis. 2022 Aug 24;75(1):e1120-e1127. doi: 10.1093/cid/ciab754.
7
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).关注的严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变异株的临床和病毒学特征:比较 B.1.1.7(阿尔法)、B.1.351(贝塔)和 B.1.617.2(德尔塔)的回顾性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e1128-e1136. doi: 10.1093/cid/ciab721.
8
Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis.变异新冠病毒株 B.1.1.7 患者的住院风险:队列分析。
BMJ. 2021 Jun 15;373:n1412. doi: 10.1136/bmj.n1412.
9
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020.2020 年夏 SARS-CoV-2 变异株在欧洲的传播。
Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y. Epub 2021 Jun 7.
10
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.英国伦敦出现的 SARS-CoV-2 B.1.1.7 谱系的基因组特征和临床效果:全基因组测序和基于医院的队列研究。
Lancet Infect Dis. 2021 Sep;21(9):1246-1256. doi: 10.1016/S1473-3099(21)00170-5. Epub 2021 Apr 12.